Therakos' Acquisition

Therakos was acquired by Mallinckrodt on August 10, 2015.

Therakos is a global provider in advancing the science of extracorporeal photopheresis (ECP) immune modulation therapy. THERAKOS Photopheresis Systems are regulatory approved integrated systems for ex…

Articles about Therakos' Acquisition: